Ketamine
Already prescribed today, by nasal spray or infusion. Ketamine is the only psychedelic-adjacent medicine with FDA approval, and researchers are now studying it for depression, bipolar disorder, and opioid addiction.
Last reviewed: November 17, 2026
The basics
Ketamine works differently from classic psychedelics. It blocks NMDA receptors, which regulate glutamate, the brain's main excitatory signal. That mechanism produces rapid antidepressant effects, sometimes within hours. The FDA-approved nasal spray esketamine (Spravato) is a purified form of one of ketamine's two mirror-image molecules. IV ketamine infusions are widely used off-label.
| Where | Status |
|---|---|
| United States, federal | Schedule III. Esketamine (Spravato) is FDA-approved for treatment-resistant depression and major depressive disorder with suicidal ideation. IV ketamine is used off-label. |
| Telehealth prescribing | DEA rules requiring an in-person visit before prescribing controlled substances via telehealth were set to take effect in 2025 but have faced repeated delays. The deadline remains in flux. |
Foundational studies
What's happening now
Capped at five. Oldest rotates to the archive at each review.
From the show
Two Psychonauts, No Filter | DMT, 5-MeO-DMT, Ketamine & Beyond
Two experienced psychonauts, decades of exploration, and one candid conversation. Dr. DREAM and Tom share their personal journeys with 5-MeO-DMT, N,N-DMT, ketamine, ibogaine, psilocybin, salvia and more.
Watch on YouTube →Go deeper
This page is for education only and is not medical advice. Ketamine is a Schedule III controlled substance. Esketamine (Spravato) is FDA-approved and must be administered in a certified healthcare setting. Talk with a qualified professional before making any health decision.